Peripheral artery disease (PAD) is a condition where narrowed arteries reduce blood flow to the arms & legs, often causing pain and mobility issues.

Treatment options for PAD, especially in the Below-the-Knee (BtK) region, involve the use of Percutaneous Transluminal Angioplasty (PTA) Balloons, Drug-Coated Balloons (DCBs), and/or Drug-Eluting Stents (DES). Combining the advantage of a BioResorbable Scaffold with the anti-proliferative action of drugs is based on the effectiveness of this concept in interventional cardiology. Since the possibility of restenosis is high, particularly in the femoro-popliteal and below-the-knee (BtK) region; it calls for a revolution in the treatment of these diseases.

Credence Below-the-Knee is a Sirolimus-Eluting Bioresorbable Peripheral Scaffold system, an indigenously developed technology by Meril. Credence BtK is designed to treat arterial blockages in the below-the-knee region, thereby preventing further complications with promising results.